Skip to content

Clinical Study of Guiyuan Decoction in Treating Decreased Ovarian Reserve Function

Clinical Study of Guiyuan Decoction in Treating Decreased Ovarian Reserve Function

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2000004004
Enrollment
Unknown
Registered
2020-08-27
Start date
2020-10-01
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

decline in ovarian reserve, DOR

Interventions

Sponsors

Longhua Hospital, Shanghai University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: (1) The age ranged from 18 to 40 years (inclusive); (2) Rare or frequent menstruation or menopause for at least 4 months; (3) Serum FSH level at least twice: 10 U / L 4 weeks); (4) AFC < 5 or serum AMH level: 0.5ng/ml < AMH < 1.1ng/ml.

Exclusion criteria

Exclusion criteria: (1) Patients are undergoing radiotherapy and chemotherapy due to malignant tumor; (2) Patients with Bilateral ovaries or uterus were removed due to gynecological surgery; (3) Patients with Ovarian hypersensitivity syndrome and other endogenous FSH increasing patients; (4) Patients with genital malformation; (5) Patients with Severe cardiovascular and cerebrovascular diseases or liver and kidney dysfunction; (6) Patients with mental disorders; (7) Those who have used hormone drugs and other immune preparations in the past 3 months.

Design outcomes

Primary

MeasureTime frame
TCM Syndrome Scale;Antimullerian hormone;Serum sex hormones;Uterus and ovarian ultrasound;

Secondary

MeasureTime frame
Blood routine;sas;

Countries

China

Contacts

Public ContactLianwei Xu

Longhua Hospital, Shanghai University of Traditional Chinese Medicine

doctorsherryxlw@163.com+86 18917763165

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026